Noninvasive evaluation of endothelial function in life style-related diseases

生活方式相关疾病内皮功能的无创评估

基本信息

  • 批准号:
    11470518
  • 负责人:
  • 金额:
    $ 7.55万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

1. Although there were many reports indicating endothelia dysfunction in the cardiovascular diseases, its evaluation method has not been established in the clinical labortary medicine. The goals of the present study were 1)to establish the routine clinical method to evaluate the endothelium-dependent vasodilation(EDV), and 2)to study the endothelial function in life-style related diseases or coronary risk factors using this methods.2. Forearm blood flow(FBF)was determined by strain-gauge plethysmography. EDV was evaluated as the increases in FBF in response to intra-arterial infusion of acetylcholine(invasive method)and to reactive hyperemia(noninvasive method).3. In patients with essential hypertension(EHT), the both responses of FBF to acetylcholine and reactive hyperemia were attenuated. There was a positive and significant correlation between the results of invasive and noninvasive methods.4. In EHT, EDV was improved by the antihypertensive treatment with ACE inhibitors, but not with calcium antagonists, diuretics or β-blockers. Regular aerobic exercise also improved EVD in EHT.5. In obese patients with EHT, EVD was smaller than in lean patients. The body weight reduction by low calorie diet improved EVD in obese patients.6. In postmenopausal women, EVD was attenuated, but improved by the estrogen replacement therapy.7. In summary, endothelial function can be evaluated by the noninvasive measurements of EDV with reactive hyperemia. EDV was disturbed in EHT, obesity and postmenopausal women. Their disturbed EDV was improved by life style modification and the specific drug treatments.
1. 虽然有许多报道表明内皮功能障碍与心血管疾病有关,但在临床检验医学中尚未建立内皮功能障碍的评价方法。本研究的目的是:1)建立评估内皮依赖性血管舒张(EDV)的常规临床方法;2)利用该方法研究生活方式相关疾病或冠状动脉危险因素中的内皮功能。前臂血流量(FBF)通过应变计体积描记仪测定。EDV通过动脉内灌注乙酰胆碱(有创法)和反应性充血(无创法)后FBF的增加来评估。在原发性高血压(EHT)患者中,FBF对乙酰胆碱和反应性充血的反应均减弱。有创法与无创法检查结果有显著正相关。在EHT中,使用ACE抑制剂治疗可以改善EDV,而钙拮抗剂、利尿剂或β受体阻滞剂则不能改善EDV。有规律的有氧运动也能改善eht患者的EVD。肥胖EHT患者EVD小于瘦弱患者。低热量饮食减轻体重可改善肥胖患者的EVD。在绝经后妇女,EVD减轻,但改善雌激素替代治疗。总之,内皮功能可以通过无创测量EDV伴反应性充血来评估。EHT、肥胖和绝经后妇女的EDV受到干扰。通过改变生活方式和特定药物治疗,他们的EDV紊乱得到改善。

项目成果

期刊论文数量(74)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ozono R, Matsumoto T, Shingu T, Oshima T, Teranishi Y, Kambe M, Matsuura H, Kajiyama G, Wang Z, Moore AF, Carey RM.: "Expression and localization of angiotensin subtype receptor proteins in the hypertensive rat heart."Am J Physiol. 278. R781-R789 (2000)
Ozono R、Matsumoto T、Shingu T、Oshima T、Teranishi Y、Kambe M、Matsuura H、Kajiyama G、Wang Z、Moore AF、Carey RM.:“血管紧张素亚型受体蛋白在高血压大鼠心脏中的表达和定位。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Toshiyuki Matsumoto: "Type 2 angiotensin II receptor is downregulated in cardiomyocytes of paticnts with heart failure"Cardiovascular Research. in press. (2000)
Toshiyuki Matsumoto:“2 型血管紧张素 II 受体在心力衰竭患者的心肌细胞中下调”心血管研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Kajiyama G, Oshima T.: "Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension : relationship between treatment periods and resistance arte
Higashi Y、Sasaki S、Nakakawa K、Matsuura H、Kajiyama G、Oshima T.:“血管紧张素转换酶抑制剂咪达普利对原发性高血压患者反应性充血的影响:治疗周期与阻力艺术之间的关系
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Higashi Y, Sasaki S, Nakagawa K, Ueda T, Yoshimizu A, Kurisu S, Matsuura H, Kajiyama G, Oshima T.: "A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hypermia in patients with esse
Higashi Y、Sasaki S、Nakakawa K、Ueda T、Yoshimizu A、Kurisu S、Matsuura H、Kajiyama G、Oshima T.:“血管紧张素转换酶抑制剂、钙拮抗剂、β-受体阻滞剂和利尿剂对反应性高血症的比较
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tetsuya Oshima: "Abnormal Ca^<2+> handling and increased Mg^<2+> permeability in platelets of hypertensive rats"Hypertens Res. 23. 651-657 (2000)
Tetsuya Oshima:“高血压大鼠血小板中Ca ^ 2 处理异常和Mg ^ 2 通透性增加”Hypertens Res。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OSHIMA Tetsuya其他文献

OSHIMA Tetsuya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OSHIMA Tetsuya', 18)}}的其他基金

Systematization of Non-invasive Evaluation of Atherosclerosis in Clinical Laboratory Medicine
临床检验医学中动脉粥样硬化无创评估的系统化
  • 批准号:
    15390177
  • 财政年份:
    2003
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of Evaluation of Endothelial Function in Clinical Laboratory Medicine.
临床检验医学内皮功能评价的建立。
  • 批准号:
    13470521
  • 财政年份:
    2001
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Evaluation of the metabolisms of calcium and magnesium in the cardiovascular diseases
心血管疾病中钙、镁代谢的评价
  • 批准号:
    08457639
  • 财政年份:
    1996
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Salt sensitivity and genetics in essential hypertension
原发性高血压的盐敏感性和遗传学
  • 批准号:
    06672293
  • 财政年份:
    1994
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Say Yes to NO: The Next Generation Scaffolds with Localized and Sustained Nitric Oxide (NO) Delivery for Central Nervous System Regeneration
对“否”说“是”:具有局部和持续一氧化氮 (NO) 输送的下一代支架,用于中枢神经系统再生
  • 批准号:
    EP/X027198/2
  • 财政年份:
    2024
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Fellowship
Thermospheric Estimation and CHaracterization with Nitric Oxide (TECHNO)
使用一氧化氮进行热层估计和表征 (TECHNO)
  • 批准号:
    2343844
  • 财政年份:
    2024
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Standard Grant
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
  • 批准号:
    23H03323
  • 财政年份:
    2023
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Multicenter randomized crossover trial to evaluate the pr ompt hemodynamic effect of inhaled nitric oxide in cardi ogenic shock patients with percutaneous ventricular assi st device (SUPPORT-pVAD)
评估吸入一氧化氮对使用经皮心室辅助装置的心源性休克患者的即时血流动力学影响的多中心随机交叉试验 (SUPPORT-pVAD)
  • 批准号:
    23K15158
  • 财政年份:
    2023
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Search for novel plant immune-priming compounds by simple screening system using nitric oxide
通过使用一氧化氮的简单筛选系统寻找新型植物免疫引发化合物
  • 批准号:
    23K19296
  • 财政年份:
    2023
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Elucidation of Ciliary Motion Inhibition Mechanism by Nitric Oxide Using Humanized Cilia Mouse Model
使用人源化纤毛小鼠模型阐明一氧化氮抑制纤毛运动的机制
  • 批准号:
    23K19659
  • 财政年份:
    2023
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Proposal of a metal complex catalyzing the direct decomposition of nitric oxide based on quantum chemistry calculations
基于量子化学计算提出催化一氧化氮直接分解的金属配合物
  • 批准号:
    22KJ2475
  • 财政年份:
    2023
  • 资助金额:
    $ 7.55万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Electrochemically Generated Inhaled Nitric Oxide (iNO) delivery via High Flow Nasal Cannula (HFNC)
通过高流量鼻插管 (HFNC) 输送电化学产生的吸入一氧化氮 (iNO)
  • 批准号:
    10637303
  • 财政年份:
    2023
  • 资助金额:
    $ 7.55万
  • 项目类别:
Response to Exercise and Nitric Oxide in PAD: the RESIST PAD Trial
PAD 对运动和一氧化氮的反应:RESIST PAD 试验
  • 批准号:
    10656845
  • 财政年份:
    2023
  • 资助金额:
    $ 7.55万
  • 项目类别:
2023 Nitric Oxide GRC and GRS
2023 一氧化氮 GRC 和 GRS
  • 批准号:
    10608028
  • 财政年份:
    2023
  • 资助金额:
    $ 7.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了